ISSN 3080-7611(Print)
ISSN 3080-762X(Online)
版权信息 · Copyright

     加入编委 / 副主编 / 同行评议专家
ISSN 3080-7611(Print)
ISSN 3080-762X(Online)

CODEN:ZLYABX
国际标准连续出版物标识符·全球唯一标识符
分配机构:美国化学文摘社(CAS)
DOI前缀:
https://doi.org/10.66106/zlyabx
国图集团 CIBTC
进口备案刊号:G015Z110

索引 检索 存档(Global Indexing)
本刊入选以下全球权威数据库,致力于研究成果的全球化无障碍传播。
DOI
ICI 哥白尼索引(波兰)
EuroPub 欧洲学术出版中心数据库(英国)
Academia 学术界(美国)
CJWK 长江文库(中国)
OALib 开放存取资源图书馆(美国)
Baidu Scholar 百度学术(中国)
Baidu Baike 百度百科(中国)
Google Scholar 谷歌学术(美国)
Microsoft Bing 微软学术(美国)
SPI-Hub 范德比尔特大学医学中心(美国)
Naver 搜遍(韩国)
Yahoo! Search(美国)
ESJI 欧亚科学期刊索引(哈萨克斯坦)
ASCI 亚洲科学引文索引(美国)
ResearchBib 研究者索引(日本)
KIND CONGRESS(阿塞拜疆)
Sci Online 科学在线(中国澳门)
SJIF 科学期刊索引(印度)
RJIF 研究期刊影响因子
SCRIBD 数字图书馆(美国)
CiteFactor 指标与信任索引(印度)
LivRe 巴西国家核能委员会CIN(巴西)
RCCSE 中国学术期刊收录(武汉大学)
Semantic Scholar 语义学者(美国)
OAJ 全球OA期刊索引(中国)
Portico 数字保存库(美国)
Scite(美国)
EBSCO(美国)
MDPI scilit(瑞士)
Crossref 交叉引用(美国)
ProQuest 科睿唯安(美国)
ResearchGate 研究之门(德国)
COAJ 开放获取期刊数据(中国)
DOAJ 开放获取期刊目录(瑞典)
J-Gate 开放获取期刊门户(印度)
WorldCat 全球联机编目数据库(美国)
J-STAGE 学术信息电子期刊库(日本)
arXiv 学术论文预印本平台(美国)
PubMed 医学检索库(美国)
PubMed Central 医学全文库(美国)
The Lens 透镜学术(澳大利亚)
Scopus 爱思唯尔·斯高帕斯(荷兰)
ChatGPT OpenAI在线服务(美国)
EZB 电子期刊图书馆(德国)

Editing and Publishing
Quest Press Limited
Address
Unit D, 7th Floor, No. 19, Rua de Pa̍k-chiông Vai, Macau
Telephone
+853 6881 9699
Email
QuestPress@hotmail.com
Web site
https://zwlc.scionline2025.com
  往期阅览 · All Issues-> 2025年 · 2025  
中外临床医学2025年第1卷第3期第60-64页,pISSN 3080-7611、eISSN 3080-762X 发布者:Quest Press 发布日期:2026/1/11
Open Access 下载0 浏览275

 

188 例血清免疫固定电泳结果及临床资料分析


李永琦

太原金域临床检验所有限公司,山西太原,030000

摘要:目的 统计2023年1月至2024年10月送检至我科室188例血清免疫固定电泳阳性结果,结合其临床诊断进行分析,为疾病的诊断提供参考依据。方法 使用法国Sebia Hydrasys 2电泳仪,对188例患者进行血清免疫固定电泳检测。结果 188例免疫固定电泳阳性结果中,按结果类型统计分析,IgG-κ型占比最高,占比为38.30%;从送检科室统计分析,血液科送检最多,占比71.28%,以IgG-κ 型为主;从诊断疾病统计分析,多发性骨髓瘤例数最多,占比为41.49%,以IgG-κ 型为主;从年龄分析,61~70岁占比最高,占比为41.49%,以IgG-κ型为主。结论 本研究,所有疾病中排在前三的依次为多发性骨髓瘤疾病、恶性肿瘤及肾病,且血清免疫固定电泳检测M 蛋白的结果分型主要以IgG-κ 型为主,而在风湿免疫科却以IgG-λ 型为主。因此,在多发性骨髓瘤疾病、恶性肿瘤及肾病临床诊疗中,具有重要的作用;同时也应重视像风湿免疫科等科室的M 蛋白检测,进而为临床多种疾病的诊断提供更全面的参考依据。

关健词:免疫固定电泳;M 蛋白;资料分析
Analysis of 188 Cases of Serum Immunofixation Electrophoresis Results and Clinical Data

Yongqi Li

Taiyuan KingMed Clinical Laboratory Co.,Ltd.,Taiyuan Shanxi 030000,China

Abstract:Objective To analyze 188 cases of positive serum immunofixation electrophoresis results sent to our department from January 2023 to October 2024, combined with their clinical diagnoses, to provide a reference for disease diagnosis.Methods Serum immunofixation electrophoresis was performed on 188 patients using the French Sebia Hydrasys 2 electrophoresis instrument.Results Among the 188 positive immunofixation electrophoresis results, statistical analysis by result type showed that the IgG-κ type accounted for the highest proportion at 38.30%. Analysis by referring departments revealed that the Hematology Department submitted the most samples, accounting for 71.28%, with the IgG-κ type being the predominant result. Statistical analysis by diagnosed diseases indicated that multiple myeloma had the highest number of cases, accounting for 41.49%, with the IgG-κ type being the most common. Age analysis showed that the 61–70 age group had the highest proportion, accounting for 41.49%, with the IgG-κ type as the predominant result.Conclusion In this study, the top three diseases were multiple myeloma, malignant tumors, and kidney diseases.The M protein results from serum immunofixation electrophoresis were predominantly of the IgG-κtype, while in the Rheumatology and Immunology Department, the IgG-λtype was more common. Therefore, serum immunofixation electrophoresis plays an important role in the clinical diagnosis and treatment of multiple myeloma, malignant tumors, and kidney diseases. At the same time, attention should also be paid to M protein testing in departments such as Rheumatology and Immunology to provide a more comprehensive reference for the diagnosis of various clinical diseases.


Keywords : Immunofixation electrophoresis; M protein; Data analysis


参考文献
[1] 全国临床检验操作规程, 尚红,王毓三,申子瑜-4版- 北京:人民卫生出版社2014.ISBN 978-7-117-19862-2.
[2] 高兴旺, 汪萍, 方根强, 等. 老年M 蛋白血症25 例临床分析[J]. 中国老年学杂志,2004,(11):1072-1073.
[3] 侯健.M 蛋白的鉴定及结果分析[J]. 中华血液学杂志,2002,(10):54-55.
[4] Mohamad Z ,Mahdi S N ,Fatemeh S .Development of a RNA sequencing-based prognostic gene signature in multiple myeloma[J].British journal of haematology, 2020,192(2):310-321.
[5] Meletios D ,Robert K ,Jean-Paul F , et al.Consensus recommendations for standard investigative workup: report of the International Myeloma Workshop Consensus Panel [J].Blood,2011,117(18):4701-5.
[6] Shirouchi Y,Kaihara K ,Sekita T , et al.Impact of M-protein detection on the response evaluations of patients undergoing treatment with the IgG-κ monoclonal antibodies daratumumab or isatuximab, and discrepancies between immunofixation electrophoresis (IFE) systems and reagents[J].Cancer medicine,2024,13(16):e70128.
[7] Joel S ,Geoffrey R ,Hans-Gerhard S .A comparison between high resolution serum protein electrophoresis and screening immunofixation for the detection of monoclonal gammopathies in serum[J].Clinical chemistry and laboratory medicine,2018,56(2):256-263.
[8] 翟妮,王昌敏.免疫固定电泳在多发性骨髓瘤辅助诊断中的临床价值[J]. 检验医学与临床,2021,18(5):582-584,588.
[9] 唐江涛,李立新,冯伟华,等.免疫固定电泳和血轻链比值诊断以肾脏损伤为首发症状的多发性骨髓瘤的价值[J]. 四川大学学报(医学版),2016,47(4):551-555.
[10] 赵祎, 王金英, 李晓阳1730 例免疫固定电泳结果及临床资料分析[J]. 标记免疫分析与临床,2022,29(4):576-579.
[11] 徐云云, 胡安群. 血清蛋白电泳、免疫固定电泳、免疫球蛋白及轻链检测在多发性骨髓瘤诊断中的应用[J]. 中南医学科学杂志,2024,52(04):599-602.DOI:10.15972/j.cnki.43-1509/r.2024.04.023.
[12] 杨蕊雪, 高露, 施菊妹. 多发性骨髓瘤的诊断进展与分期[J]. 中国癌症杂志,2014,24(10):727-731.
[13] 徐鑫鑫, 保方, 苏建友, 等. 免疫固定电泳及血清蛋白电泳检测相关的临床资料分析[J]. 标记免疫分析与临床,2024,31(08):1529-1534.
[14] CAERS J,WITHOFS N,HILLENGASS J,etal.The role of positron emission tomography-computed tomography and magnetic resonance imaging in diagnosis and follow up of multiple myeloma[J].Haematologica, 2014,99(4):629-637.
论文收录证明 / 文献检索报告
Document Retrieval Certificate / Proof of Publication Indexing
作者贡献声明 / 贡献确认书
Author Contribution Statement / Certificate of Authorship Contribution
同行评审报告 / 评审意见
Peer Review Report / Peer Review Comments
利益冲突
Conflict of Interest
作者声明不存在任何利益冲突。
The author declares no conflict of interest.
版权声明
Copyright Statement
本文采用知识共享“署名 4.0 国际”许可 (CC BY 4.0) 进行许可。许可协议详情请访问: https://creativecommons.org/licenses/by/4.0/
This article is licensed under a Creative Commons Attribution 4.0 International License (CC BY 4.0). For details of the license, please visit:https://creativecommons.org/licenses/by/4.0/.

 
Peer Review
同行评审
Editorial Services
编辑服务
Research Ethics Policy
研究伦理政策
Contributorship & Authorship
贡献者与署名
Quest Press / Macau Sino-Foreign Medical Publishing Ltd.
关于 Quest Press / Macau Sino-Foreign Medical Publishing Ltd.
Global Indexing
全球索引
Copyright Licensing
版权许可
Data Sharing Policy
数据共享政策
Appeal/Correction/Retraction
申诉/更正/撤回
Online Submission
线上投稿
To the Librarian
致图书馆员
Open Access Statement
开放获取声明
Misconduct Handling Policy
处理不端行为政策
Content Licensing
内容许可
Guidelines for Reviewers
审稿人指南
Quality Control Mechanism
质量把控机制
Academic Misconduct Screening Policy
学术不端筛查政策
Advertising Policy
广告政策
Article Processing Charge (APC)
文章处理费
Publication Ethics Policy
出版伦理政策
Joining the Editorial Board, Associate Editors, Peer Reviewers, and Editor-in-Chief
加入编委、副主编、同行评审专家及主编
Quest Press
Bridging Research to a Global Stage.
academia
© 2025-2026 Quest Press Ltd.
Address: Unit D, 7th Floor, No. 19, Rua de Pa̍k-chiông Vai, Macau
Tel: +853 6881 9699 / Email: QuestPress@hotmail.com
The QUEST PRESS publishes articles under the following open access license.
Quest Press
is a member of the following organizations.